The effect of oral Tramadol in prevention and treatment of shivering during and after surgery

The effect of oral Tramadol in prevention and treatment of Intra & post-operative shivering in inguinal surgery by spinal anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190928044907N2

Enrollment

200

Registered

2021-05-02

Start date

2021-05-05

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peri operative shivering. Chills (without fever)

Interventions

Intervention 1: Intervention group: Patients receiving the drug receive a 50 mg tablet of oral tramadol made by Caspian Pharmaceutical Company, single dose and 2 hours before the start of elective sur

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age range 18 to 70 years Classes one and two ASA Elective surgery Inguinal surgery Spinal anesthesia non opium addict

Exclusion criteria

Exclusion criteria: Patient refuse to spinal anesthesia Clinical ASA class three or more Emergency surgery indications Any substance addiction History of allergies to tramadol or other Opiates History of preoperative shivering History of respiratory depression

Design outcomes

Primary

Measure	Time frame
Shivering during and after surgery. Timepoint: At beginning, 5? 10? 15? 20? 30? 45? 60? 75? 90? 120 minutes after beginning of surgery. Method of measurement: Researcher's observation for the incidence and severity of shivering based on a comparison of Crassell ratings.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Hossein Hamidi M.D.

Babol University of Medical Sciences

a.hamidi@mubabol.ac.ir+98 11 3223 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026